XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Stockholders’ Equity - 12 months ended Dec. 31, 2022 - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A Common Stock
Class B Common Stock
Members' Equity
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional paid-in capital
Non-controlling interest
Retained earnings (Accumulated deficit)
Retained earnings (Accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance at Dec. 31, 2021         $ 0.0            
Increase (Decrease) in Members' Equity [Roll Forward]                      
Proceeds from exercises of stock options $ 9.4             $ 7.1 $ 2.3    
Net loss (783.7)               (206.9) $ (576.8)  
Beginning balance (in shares) at Dec. 31, 2021     170,987,365 56,838,744   170,987,365 56,838,744        
Beginning balance at Dec. 31, 2021 1,492.9 $ (0.4)       $ 1.7 $ 0.6 1,101.3 369.6 19.7 $ (0.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Equity-based compensation (in shares)             1,248,188        
Equity-based compensation 47.0             17.9 29.1    
Vesting of restricted stock units, net of shares withheld to cover payroll taxes (in shares)           160,212          
Vesting of restricted stock units, net of shares withheld to cover payroll taxes (0.6)             (0.6)      
Proceeds from exercises of stock options (in shares)           2,182,545          
Issuance of Class A common stock under stock purchase plan (in shares)           192,101          
Issuance of Class A common stock under stock purchase plan 2.9             2.2 0.7    
Tax payments on behalf of non-controlling interest (6.5)               (6.5)    
Exchange of LLC units (in shares)           504,173 (504,173)        
Exchange of LLC units 0.0             2.3 (2.3)    
Equity impact of tax receivable agreement liability and deferred taxes arising from LLC Interest ownership exchanges (0.4)             (0.4)      
Issuance of Class A common stock in connection with Caravan Health acquisition, net of tax (in shares)           4,762,134          
Issuance of Class A common stock in connection with Caravan Health acquisition, net of tax 60.0         $ 0.1   52.7 7.2    
Net loss (783.7)               (206.9) (576.8)  
Ending balance (in shares) at Dec. 31, 2022     178,788,530 57,582,759   178,788,530 57,582,759        
Ending balance at Dec. 31, 2022 $ 820.6         $ 1.8 $ 0.6 $ 1,182.5 $ 193.2 $ (557.5) $ (0.4)